MiR-181a, another miRNA upregulated by TGF-β, promoted TGF-β-mediated EMT and metastasis in breast cancer [112] and via repression of SMAD7 in ovarian cancer progression [113]. The gene discussed is TGFB1; the disease is ovarian carcinoma.